Loading…

Overcoming Resistance Without the Risk of Reaction: Use of Afatinib and Panitumumab in Two Cases of Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer With T790M Mutations

Saved in:

Bibliographic Details
Published in:	Clinical lung cancer 2015-09, Vol.16 (5), p.e97-e99
Main Authors:	Castellanos, Emily H, Rivera, Gabriel, Wakelee, Heather, Horn, Leora
Format:	Article
Language:	English
Subjects:	Aged Antibodies, Monoclonal - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology Drug Resistance, Neoplasm Female Hematology, Oncology and Palliative Medicine Humans Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Middle Aged Mutation Pulmonary/Respiratory Quinazolines - administration & dosage Receptor, Epidermal Growth Factor - genetics
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!